10x Genomics
TXG
$14.00
Share price
-4.37%
Change (1 day)
-31.07%
Change (1 year)
Categories
10x Genomics (TXG) - Total assets
Total assets on the balance sheet as of March 2025 : $0.90 Billion USD
According to 10x Genomics 's latest financial reports the company's total assets are $0.90 Billion USD. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
10x Genomics - Total assets on balance sheet (from 2018 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | $0.91 B | -4.82% |
| 2023-12-31 | $0.96 B | -6.2% |
| 2022-12-31 | $1.02 B | 1% |
| 2021-12-31 | $1.01 B | 9.63% |
| 2020-12-31 | $0.92 B | 53.38% |
| 2019-12-31 | $0.60 B | 387.43% |
| 2018-12-31 | $0.12 B | 64.41% |
| 2017-12-31 | $75.6 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | $1.24 B | 38.24% | Jersey |
 Novavax NVAX | $1.29 B | 43.13% | 🇺🇸 USA |
 Organovo ONVO | $14.65 M | -98.38% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.20 B | -77.61% | 🇬🇧 UK |